Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
Authors
Keywords
Cancer treatment, T cell receptors, Blood, T cells, Somatic mutation, Cancer immunotherapy, Immune response, RNA sequencing
Journal
PLOS MEDICINE
Volume 14, Issue 5, Pages e1002309
Publisher
Public Library of Science (PLoS)
Online
2017-05-27
DOI
10.1371/journal.pmed.1002309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma
- (2016) Guru Sonpavde et al. JOURNAL OF UROLOGY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination
- (2016) M. S. Hsu et al. Cancer Immunology Research
- Dynamics of the Cytotoxic T Cell Response to a Model of Acute Viral Infection
- (2015) William S. DeWitt et al. JOURNAL OF VIROLOGY
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
- (2015) Tyler S. Alioto et al. Nature Communications
- Detection of Minimal Residual Disease in B Lymphoblastic Leukemia by High-Throughput Sequencing of IGH
- (2014) D. Wu et al. CLINICAL CANCER RESEARCH
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- IMGT®, the international ImMunoGeneTics information system® 25 years on
- (2014) Marie-Paule Lefranc et al. NUCLEIC ACIDS RESEARCH
- Improved Survival with T Cell Clonotype Stability After Anti-CTLA-4 Treatment in Cancer Patients
- (2014) E. Cha et al. Science Translational Medicine
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- Comprehensive assessment of T-cell receptor -chain diversity in T cells
- (2009) H. S. Robins et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started